Global Neurointerventional Devices Market Expansion at 7.2% CAGR, Valued at $3.65 Billion by 2029

Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.

What Are the Neurointerventional Devices Market Size Forecast for 2025?
The expansion of the neurointerventional devices market has been vigorous in the past few years, with forecasts predicting an increase from $2.57 billion in 2024 to $2.76 billion in 2025, reflecting a compound annual growth rate (CAGR) of 7.5%. This historical growth trend can be connected to several factors including enhanced cognizance of the importance of early detection, the surge in specialized neurointerventional centers, rising incidences of lifestyle diseases such as diabetes and hypertension, heightened requirements for superior patient results, and increased backing from both public and private healthcare entities.

What Is the Market Size Outlook for Neurointerventional Devices Until 2029?
In the coming years, the neurointerventional devices market is predicted to experience solid growth. It is set to expand to $3.65 billion by 2029, with a compound annual growth rate (CAGR) of 7.2%. Factors contributing to this projected growth during the forecast period include a growing inclination for image-guided surgical procedures, an increase in neurovascular research funding, approval of new neurointerventional products, increased collaboration and acquisitions among device manufacturers, and a rising demand for personalized treatment strategies. Trends expected during this period consist of advancements in robot-assisted neurointerventions, innovative catheter and stent designing, advanced utilization of artificial intelligence in diagnostic imaging, incorporation of augmented reality in surgical planning, and technological breakthroughs in embolization and thrombectomy methods.

Explore The Complete Report Now:
https://www.thebusinessresearchcompany.com/report/neurointerventional-devices-global-market-report

What Are the Major Factors Driving Demand in the Neurointerventional Devices Market?
The upward trend in neurological disorders is predicted to drive the growth of the neurointerventional devices market in the future. Neurological disorders, affecting the brain, spinal cord or nerves and disrupting their normal operations, are becoming increasingly prevalent. This surge is largely due to the aging global population, as the advancing age can heighten the potential for neurodegenerative conditions due to the natural deterioration of brain functionality and cell repair mechanisms. Neurointerventional devices facilitate treatment for these disorders by paving way for minimally invasive procedures for diagnosis and management of conditions like brain aneurysms, strokes, and vascular malformations. This, in turn, lessens the risk and recovery time, thereby enhancing patient outcomes. For example, the Alzheimer's Association, a US-based nonprofit voluntary health organization, stated in a report in April 2024 that, in 2022, 6.5 million Americans aged 65 and older were found to have Alzheimer's dementia, which escalated to 6.9 million in 2024. Consequently, the escalating trend of neurological disorders is fuelling the growth of the neurointerventional devices market.

Get Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=25846&type=smp

How Are End-Use Segments Shaping the Neurointerventional Devices Market Outlook?
The neurointerventional devices market covered in this report is segmented -

1) By Product: Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Device, Flow Diverters Device, Intrasaccular Device, Other Products
2) By Indication: Brain Aneurysm, Stroke, Other Indications
3) By Technique: Neurothrombectomy Procedure, Cerebral Angiography, Stenting, Coiling Procedures, Flow Disruption
4) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Research Institutes

Subsegments:
1) By Embolic Coils: Bare Platinum Coils, Coated Or Modified Coils, Complex-Shaped Coils, Detachable Coils
2) By Carotid Stents: Open-Cell Stents, Closed-Cell Stents, Hybrid-Cell Stents, Drug-Eluting Stents
3) By Intracranial Stents: Self-Expanding Stents, Balloon-Expandable Stents, Drug-Eluting Stents
4) By Neurovascular Thrombectomy Devices: Stent Retrievers, Aspiration Catheters, Combined Thrombectomy Systems
5) By Embolic Protection Devices: Distal Filters, Proximal Occlusion Devices, Distal Occlusion Devices
6) By Flow Diverters Devices: Braided Flow Diverters, Dual-Layer Flow Diverters, Coated Flow Diverters
7) By Intrasaccular Devices: Woven Mesh Implants, Expandable Mesh Baskets, Flow Disrupting Implants
8) By Other Products: Microcatheters, Guidewires, Balloon Catheters, Distal Access Catheters

What Are the Strategic Trends Transforming the Neurointerventional Devices Market Landscape?
Leading enterprises in the neurointerventional devices market are prioritizing technological progress, such as the use of AI-assisted navigation systems, to improve the accuracy of procedures, decrease the duration of intervention, and enhance patient results in intricate neurovascular treatments. The term AI-assisted navigation systems pertains to state-of-the-art technologies that apply artificial intelligence algorithms to direct neurointerventional protocol in real-time. These systems interpret medical imaging data to ensure better visualization, automate route planning, and enable precise navigation of devices through the complicated vasculature of the brain, thus optimizing accuracy, curtailing procedure duration, and reducing risks. For example, Medtronic plc, a healthcare technology firm based in Ireland, introduced the Medtronic Neurovascular Co Lab Platform in October 2022 to spur innovation in stroke therapy. This platform encourages cooperation between startups, doctors, and institutions by providing a constantly available virtual portal for submitting ideas, which are then assessed and developed with the help of Medtronic's know-how, financial backing, and networks, in order to swiftly create promising neurovascular treatments and enhance patient results.

Customize Your Insights And Get The Full Report Here:
https://www.thebusinessresearchcompany.com/customise?id=25846&type=smp

Who Are the Prominent Companies in the Neurointerventional Devices Market by ?
Major companies operating in the neurointerventional devices market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, Terumo Corporation, Kaneka Corporation, Cook Medical LLC, Integra LifeSciences Holdings Corporation, Merit Medical Systems Inc., MicroPort Scientific Corporation, Penumbra Inc., Asahi Intecc Co. Ltd., MicroVention Inc., Phenox GmbH, Balton Sp. z o.o., Zylox-Tonbridge Medical Technology Co. Ltd., Balt Group SAS, Veiva Scientific Co. Ltd., InspireMD Inc.

Which Region Is Expected to See the Highest CAGR in the Neurointerventional Devices Market?
North America was the largest region in the neurointerventional market in 2024. The regions covered in the neurointerventional devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Speak With Our Expert:
Saumya Sahay
Americas +1 310-496-7795,
Asia +44 7882 955267 & +91 8897263534,
Europe +44 7882 955267
Email: saumyas@tbrc.info
The Business Research Company - www.thebusinessresearchcompany.com

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.